Airsculpt Technologies Inc’s filing revealed that its Director Feinstein Adam T acquired Company’s shares for reported $4.0 million on Jun 09 ’25. In the deal valued at $4.00 per share,1,000,000 shares were bought. As a result of this transaction, Feinstein Adam T now holds 14,038,819 shares worth roughly $71.04 million.
Then, Rollins Aaron bought 2,118 shares, generating $7,629 in total proceeds. Upon buying the shares at $3.60, the Executive Chairman now owns 15,146,039 shares.
Before that, Jashnani Yogesh bought 7,000 shares. Airsculpt Technologies Inc shares valued at $18,532 were divested by the Chief Executive Officer at a price of $2.65 per share. As a result of the transaction, Jashnani Yogesh now holds 464,879 shares, worth roughly $2.35 million.
BTIG Research initiated its Airsculpt Technologies Inc [AIRS] rating to a Neutral in a research note published recently. A number of analysts have revised their coverage, including Leerink Partners’s analysts, who decreased its forecast for the stock in mid May from “an Outperform” to “a Market perform”. Piper Sandler also remained covering AIRS and has decreased its forecast on November 11, 2022 with a “Neutral” recommendation from previously “an Overweight” rating. Morgan Stanley revised its rating on June 16, 2022. It rated AIRS as “an Equal-weight” which previously was an “an Overweight”.
Price Performance Review of AIRS
On Monday, Airsculpt Technologies Inc [NASDAQ:AIRS] saw its stock jump 11.21% to $5.06. Over the last five days, the stock has gained 0.20%. Airsculpt Technologies Inc shares have fallen nearly -2.50% since the year began. Nevertheless, the stocks have risen 20.48% over the past one year. While a 52-week high of $9.20 was reached on 01/08/25, a 52-week low of $1.53 was recorded on 04/21/25.
Levels Of Support And Resistance For AIRS Stock
The 24-hour chart illustrates a support level at 4.74, which if violated will result in even more drops to 4.42. On the upside, there is a resistance level at 5.25. A further resistance level may holdings at 5.44.
The most recent change occurred on November 23, 2021 when SVB Leerink began covering the stock and recommended ‘”an Outperform”‘ rating along with a $26 price target.
